25 reports

  • Predicted Gene Therapy Approvals
  • 10.1.2 Improving upstream titer and downstream recovery

RMAT designation allows expedited review of regenerative medicines, including certain gene therapies, if they target an unmet need in a serious or life-threatening indication.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • Supply

MARKET OVERVIEW Cell and Tissue Culture Supplies: Vital Components of Cell Culture Techniques Table ##: Global Cell Culture Media and Reagents Market by Application (2018E): Percentage Breakdown of Value Sales for Biopharmaceuticals & Therapeutics, Cancer and Biotech Research, Drug Scre

  • Medical Biotechnology
  • Regenerative Medicine
  • Tissue Engineering
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Africa
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • China
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • India
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Germany
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • France
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Brazil
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Saudi Arabia
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Russia
  • Supply

Tissue Engineering & Regenerative Medicine ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Ireland
  • Supply

##: Approved gene therapies by country, September 2018 ## Figure ##: Gene therapy pipeline by therapy area ## Figure ##: Key challenges to reimbursement of gene therapies ## Figure ##: Ethical concerns related to hypothetical gene therapy for brain-related conditions ## Figure ##: The Allian

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • Supply

Approvals Outlook TABLE ##: CELL THERAPY APPROVALS documents advocating " a modern, efficient and least burdensome framework" for speeding regenerative medicines to market, including innovative trial designs whereby ##.

  • Regenerative Medicine
  • United States
  • Supply
  • Novartis AG
  • PROVENGE group
  • BATAVIA BIOSERVICES
  • BAVARIAN NORDIC

REGENERATIVE MEDICINE INSTITUTE ##.

  • Regenerative Medicine
  • North America
  • United States
  • Supply
  • Lonza Group Ltd

This is the serum of choice when developing tissue engineered and regenerative medicine products.

  • Regenerative Medicine
  • China
  • East Asia
  • Supply
  • Grifols, S.A.
  • IN NORTH AMERICA

CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE ##.

  • Regenerative Medicine
  • United States
  • Supply
  • Lonza Group Ltd
  • Sanofi S.A.

THE WIDE RANGE OF BIOREPOSITORIES AT THE CORIELL INSTITUTE (SUCH AS NATIONAL INSTITUTE OF AGING, NATIONAL HUMAN GENOME RESEARCH INSTITUTE AND CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINES) HAVE DISTRIBUTED MILLIONS OF CELL LINES AND DNA SAMPLES TO SEVERAL COUNTRIES ACROSS THE WOR

  • Regenerative Medicine
  • Supply
  • Abzena plc
  • Lonza Group Ltd
  • Selexis SA

FEB ##, 2018: THE ALLIANCE FOR REGENERATIVE MEDICINE ANNOUNCES INITIAL SLATE OF PRESENTING COMPANIES AT THE SIXTH ANNUAL CELL & GENE THERAPY INVESTOR DAY The Alliance for Regenerative Medicine announced its annual Cell & Gene Therapy Investor Day will take

  • Medical Biotechnology
  • Regenerative Medicine
  • United Kingdom
  • Supply
  • Oxford BioMedica plc

CellSeed Inc (CellSeed) is a developer of regenerative medicine.

  • Regenerative Medicine
  • Germany
  • Sweden
  • Supply
  • CellSeed Inc.
  • CELL THERAPY CATAPULT TO ENTER INTO AGREEMENT WITH JAPANESE SOCIETY FOR REGENERATIVE MEDICINE
  • ASTERIAS BIOTHERAPEUTICS ENTERS INTO AGREEMENT WITH CELL THERAPY CATAPULT

Cell Therapy Catapult Ltd Parent CELL THERAPY CATAPULT TO ENTER INTO AGREEMENT WITH JAPANESE SOCIETY FOR REGENERATIVE MEDICINE Cell Therapy Catapult to Enter into Agreement with Japanese Society for Regenerative Medicine Cell Therapy Catapult Ltd (CGT Catapult), a

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • United Kingdom
  • Supply
  • Cobra Biologics Enters into Agreement with Centre for Process Innovation
  • Cobra Biologics Partners with Touchlight Genetics

This agreement enables Cobra Biologics and Centre for Process Innovation to advance development of regenerative medicines.

  • Medical Biotechnology
  • Pharmaceutical
  • Regenerative Medicine
  • United Kingdom
  • Supply

CellSeed Inc (CellSeed) is a developer of regenerative medicine.

  • Regenerative Medicine
  • Germany
  • Sweden
  • Supply
  • CellSeed Inc.

## Marketing Assessment Question ## – What is your preferred provider for purchasing iPSC products?

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Japan
  • Supply
  • OVERVIEW

The Life Technologies division of Thermo Fisher, through its Stem Cells and Regenerative Medicine Division, offers a range of embryonic stem cell (ESC) and induced-pluripotent stem cell (iPSC) reagents of animal-free origin.

  • Regenerative Medicine
  • Supply
  • Life Technologies Corporation
  • Sigma-Aldrich
  • Thermo Fisher Scientific, Inc.